PolyPid to Present at First World Association Against Infection in Orthopaedics and Trauma Congress

Virtual Presentation to be led by PolyPid Co-Founder and CSO on August 28, 2021 PETACH TIKVA, Israel, Aug. 17, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD ), a late-stage biopharma focusing on developing targeted, locally administered and prolonged-release therapeutics to improve surgical